ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FF01 | BioTech | Nivolumab - 100mg/10ml | 8331/388 | 120715/1 | OPDIVO | 100mg/10ml | 1 x 10ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | L.L | 2.44 | E2 | Bristol-Myers Squibb Company | USA | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FF01 | BioTech | Nivolumab - 100mg/10ml | 8331 | 120715/1 | OPDIVO | 100mg/10ml | 1 x 10ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | 117,224,380 L.L | 2.44 | E2 | Bristol-Myers Squibb Company | USA | 12/12/20 | 0 |